Surgery for hepatocellular carcinoma with tumor thrombosis in inferior vena cava: A case report

被引:0
作者
Zhang, Zun-Yi [1 ,2 ]
Zhang, Er-Lei [1 ,2 ]
Zhang, Bi-Xiang [1 ,2 ]
Zhang, Wei [1 ,2 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Res Lab, 1095 Jiefang Rd, Wuhan 430000, Hubei, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Hepat Surg Ctr,Dept Hepat Surg, 1095 Jiefang Rd, Wuhan 430000, Hubei, Peoples R China
基金
中国国家自然科学基金;
关键词
Hepatocellular carcinoma; Tumor thrombosis; Inferior vena cava; Hepatectomy; Thrombectomy; Sorafenib; Cardiopulmonary bypass; Case report; LIVER RESECTION; HEPATIC VEIN; SURGICAL-TREATMENT; Y-90; MICROSPHERES; SORAFENIB; RADIOEMBOLIZATION; GUIDELINES; SECONDARY; INVASION; OUTCOMES;
D O I
10.12998/wjcc.v9.i36.11495
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Hepatocellular carcinoma (HCC) accompanied by a tumor thrombus is very common. However, the treatment strategy is controversial and varies by the location of the thrombus. CASE SUMMARY We report herein a case of HCC with a tumor thrombus in the suprahepatic inferior vena cava (IVC), which was successfully treated by hepatectomy combined with thrombectomy following sorafenib chemotherapy. A 47-year-old woman with chronic hepatitis was diagnosed with HCC. Computed tomography and magnetic resonance imaging showed that the tumor lesion was located in the right half of the liver, and a tumor thrombus was detected in the suprahepatic IVC near the right atrium. After multi departmental discussion and patient informed consent, right major hepatectomy and total removal of the tumor thrombus were successfully performed under cardiopulmonary bypass. There were no serious complications after surgery. Following sorafenib treatment, no recurrence has been detected so far (11 mo later). CONCLUSION Surgical treatment followed by adjuvant sorafenib therapy might be an acceptable choice for HCC patients with tumor thrombosis in the IVC.
引用
收藏
页码:11495 / 11503
页数:9
相关论文
共 29 条
  • [1] Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
    Bruix, Jordi
    Takayama, Tadatoshi
    Mazzaferro, Vincenzo
    Chau, Gar-Yang
    Yang, Jiamei
    Kudo, Masatoshi
    Cai, Jianqiang
    Poon, Ronnie T.
    Han, Kwang-Hyub
    Tak, Won Young
    Lee, Han Chu
    Song, Tianqiang
    Roayaie, Sasan
    Bolondi, Luigi
    Lee, Kwan Sik
    Makuuchi, Masatoshi
    Souza, Fabricio
    Le Berre, Marie-Aude
    Meinhardt, Gerold
    Llovet, Josep M.
    [J]. LANCET ONCOLOGY, 2015, 16 (13) : 1344 - 1354
  • [2] Modified technique of hepatic vascular exclusion: effect on blood loss during complex mesohepatectomy in hepatocellular carcinoma patients with cirrhosis
    Chen, Xiao-ping
    Zhang, Zhi-wei
    Zhang, Bi-xiang
    Chen, Yi-fa
    Huang, Zhi-yong
    Zhang, Wan-guang
    He, Song-qing
    Qiu, Fa-zu
    [J]. LANGENBECKS ARCHIVES OF SURGERY, 2006, 391 (03) : 209 - 215
  • [3] Effects of location and extension of portal vein tumor thrombus on long-term outcomes of surgical treatment for hepatocellular carcinoma
    Chen, XP
    Qiu, FZ
    Wu, ZD
    Zhang, ZW
    Huang, ZY
    Chen, YF
    Zhang, BX
    He, SQ
    Zhang, WG
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (07) : 940 - 946
  • [4] Use of hepatectomy and splenectomy to treat hepatocellular carcinoma with cirrhotic hypersplenism
    Chen, XP
    Wu, ZD
    Huang, ZY
    Qiu, FZ
    [J]. BRITISH JOURNAL OF SURGERY, 2005, 92 (03) : 334 - 339
  • [5] Cheng SQ, 2007, HEPATO-GASTROENTEROL, V54, P499
  • [6] Acute heart failure caused by a giant hepatocellular metastatic tumor of the right atrium
    Dedeilias, Panagiotis
    Nenekidis, Ioannis
    Koukis, Ioannis
    Anagnostakou, Vania
    Paparizou, Niki
    Zompolos, Spyros
    Apostolakis, Efstratios
    [J]. JOURNAL OF CARDIOTHORACIC SURGERY, 2011, 6
  • [7] Hepatocellular carcinoma
    Forner, Alejandro
    Reig, Maria
    Bruix, Jordi
    [J]. LANCET, 2018, 391 (10127) : 1301 - 1314
  • [8] Hepatocellular carcinoma
    Forner, Alejandro
    Llovet, Josep M.
    Bruix, Jordi
    [J]. LANCET, 2012, 379 (9822) : 1245 - 1255
  • [9] Should we apply sorafenib in hepatocellular carcinoma patients with microvascular invasion after curative hepatectomy?
    Huang, Yun
    Zhang, Zeyu
    Zhou, Yufan
    Yang, Jiajin
    Hu, Kuan
    Wang, Zhiming
    [J]. ONCOTARGETS AND THERAPY, 2019, 12 : 541 - 548
  • [10] Outcomes of non-anatomic liver resection for hepatocellular carcinoma in the patients with liver cirrhosis and analysis of prognostic factors
    Huang, Zhi-yong
    Chen, Gen
    Hao, Xiao-yi
    Cai, Rong-yao
    Zhao, Yin-feng
    Chen, Xiao-ping
    [J]. LANGENBECKS ARCHIVES OF SURGERY, 2011, 396 (02) : 193 - 199